humira

Apple (AAPL) to settle suit related to iTunes gift card scam - report. (00:23) TikTok (BDANCE) sets sights on Amazon (AMZN) with goal of growing e-commerce tenfold. (01:46) CVS to drop Humira (ABBV) from certain formularies, cover biosimilars instead. (02:36)

Episode transcripts seekingalpha.com/wsb.

Show links:
Biggest stock movers today: Cal-Maine Foods, FuboTV and more
Microsoft adds Copilot AI button in first big change to PC keyboard in decades
Mark Zuckerberg sold $428M worth of Meta stock at the end of 2023
Piper Sandler downgrades Apple on iPhone sales and macroeconomic worries

Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

After decades of patent protection, the wildly successful arthritis and autoimmune drug Humira is finally facing competition. WSJ’s Jared Hopkins on what that could mean for patients and the drug industry. Further Reading: - Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S.  - AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira  Further Listening: - How Big Pharma Lost Its Swagger  Learn more about your ad choices. Visit megaphone.fm/adchoices